Ignite Creation Date:
2025-12-25 @ 2:19 AM
Ignite Modification Date:
2025-12-28 @ 10:26 PM
Study NCT ID:
NCT04218734
Status:
COMPLETED
Last Update Posted:
2021-06-28
First Post:
2020-01-03
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
A Study of DBPR108 and Metformin Hydrochloride Combination Therapy in Patients With T2DM
Sponsor:
CSPC ZhongQi Pharmaceutical Technology Co., Ltd.
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
CSPC/DBPR108201903/PRO-III-2
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None